UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000780 |
|---|---|
| Receipt number | R000000937 |
| Scientific Title | A randomized, double-blind, placebo-controlled, cross-over, multi-center study concerning the efficacy and safety of amantadine hydrochloride in treatment of dyskinesias in Parkinson's disease |
| Date of disclosure of the study information | 2007/08/01 |
| Last modified on | 2014/01/24 12:23:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2007/07/30 08:48:43 | ||
| 2 | Update | 2008/08/01 08:42:00 | Recruitment status Last follow-up date |
|
| 3 | Update | 2009/03/05 12:10:04 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 4 | Update | 2013/12/11 12:18:32 | UMIN ID1 |
|
| 5 | Update | 2013/12/11 12:23:14 | Publication of results URL related to results and publications Results |
|
| 6 | Update | 2014/01/24 12:23:15 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
